Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pantel, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hosch, SB; Braun, S; Pantel, K
      Characterization of disseminated tumor cells

      SEMINARS IN SURGICAL ONCOLOGY
    2. Pantel, K; Otte, M
      Occult micrometastasis: enrichment, identification and characterization ofsingle disseminated tumour cells

      SEMINARS IN CANCER BIOLOGY
    3. Braun, S; Schindlbeck, C; Hepp, F; Janni, W; Kentenich, C; Reithmuller, G; Pantel, K
      Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse

      JOURNAL OF CLINICAL ONCOLOGY
    4. Braun, S; Harbeck, N; Pantel, K
      Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? - Reply

      JOURNAL OF CLINICAL ONCOLOGY
    5. Maletz, K; Kufer, P; Mack, M; Raum, T; Pantel, K; Riethmuller, G; Gruber, R
      Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity

      INTERNATIONAL JOURNAL OF CANCER
    6. Braun, S; Schlimok, G; Heumos, I; Schaller, G; Riethdorf, L; Riethmuller, C; Pantel, K
      erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients

      CANCER RESEARCH
    7. Otte, M; Zafrakas, M; Riethdorf, L; Pichlmeier, U; Loning, T; Janicke, F; Pantel, K
      MAGE-A gene expression pattern in primary breast cancer

      CANCER RESEARCH
    8. Janni, W; Hepp, F; Rjosk, D; Kentenich, C; Strobl, B; Schindlbeck, C; Hantschmann, P; Sommer, H; Pantel, K; Braun, S
      The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence

      CANCER
    9. Zippelius, A; Lutterbuse, R; Riethmuller, G; Pantel, K
      Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells

      CLINICAL CANCER RESEARCH
    10. Passlick, B; Sienel, W; Seen-Hibler, R; Wockel, W; Thetter, O; Mutschler, W; Pantel, K
      Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer

      CLINICAL CANCER RESEARCH
    11. Pantel, K; Doeberitz, MV
      Detection and clinical relevance of micrometastatic cancer cells

      CURRENT OPINION IN ONCOLOGY
    12. Braun, S; Kentenich, C; Janni, W; Hepp, F; de Waal, J; Willgeroth, F; Sommer, H; Pantel, K
      Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients

      JOURNAL OF CLINICAL ONCOLOGY
    13. Pantel, K; Otte, M
      Identification and characterisation of minimal residual disease in solid tumors

      ACTA MEDICA AUSTRIACA
    14. Braun, S; Schlimok, G; Pantel, K
      Bone marrow metastases in breast cancer - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    15. Braun, S; Pantel, K; Muller, P; Janni, W; Hepp, F; Kentenich, CRM; Gastroph, S; Wischnik, A; Dimpfl, T; Kindermann, G; Riethmuller, G; Schlimok, G
      Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.

      NEW ENGLAND JOURNAL OF MEDICINE
    16. Passlick, B; Sienel, W; Seen-Hibler, R; Wockel, W; Thetter, O; Pantel, K
      The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells

      INTERNATIONAL JOURNAL OF CANCER
    17. Hosch, S; Kraus, J; Scheunemann, P; Izbicki, JR; Schneider, C; Schumacher, U; Witter, K; Speicher, MR; Pantel, K
      Malignant potential and cytogenetic characteristics of occult disseminatedtumor cells in esophageal cancer

      CANCER RESEARCH
    18. Gehling, UM; Ergun, S; Schumacher, U; Wagener, C; Pantel, K; Otte, M; Schuch, G; Schafhausen, P; Mende, T; Kilic, N; Kluge, K; Schafer, B; Hossfeld, DK; Fiedler, W
      In vitro differentiation of endothelial cells from AC133-positive progenitor cells

      BLOOD
    19. Braun, S; Pantel, K
      Diagnostic and clinical impact of disseminated tumour cells in bone marrow

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    20. Borgen, E; Naume, B; Nesland, JM; Kvalheim, G; Beiske, K; Fodstad, O; Diel, I; Solomayer, EF; Theocharous, P; Coombes, RC; Smith, BM; Wunder, E; Marolleau, JP; Garcia, J; Pantel, K
      Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells

      CYTOTHERAPY
    21. Scheunemann, P; Hosch, SB; Witter, K; Kraus, J; Speicher, MR; Pantel, K; Izbicki, JR
      Biological relevance of occult tumor cells in a lymph node of a patient with resectable esophageal cancer

      LANGENBECKS ARCHIVES OF SURGERY
    22. Hosch, SB; Stoecklein, N; Pichlmeier, U; Pantel, K; Izbicki, JR
      Plakoglobin downregulation as an indicator of an unfavourable prognosis inesophageal cancer

      LANGENBECKS ARCHIVES OF SURGERY
    23. Braun, S; Pantel, K
      Micrometastatic bone marrow involvement: detection and prognostic significance

      MEDICAL ONCOLOGY
    24. Braun, S; Hepp, F; Kentenich, CRM; Janni, W; Pantel, K; Riethmuller, G; Willgeroth, F; Sommer, HL
      Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow

      CLINICAL CANCER RESEARCH
    25. Pantel, K; Witter, K
      Detection of disseminated epithelial tumor cells: Methods and clinical implications

      INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    26. Kubuschok, B; Passlick, B; Izbicki, JR; Thetter, O; Pantel, K
      Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer

      JOURNAL OF CLINICAL ONCOLOGY
    27. Pantel, K
      Minimal residual cancer: Diagnostic approaches, prognostic relevance, biology and antibody therapy

      TUMORDIAGNOSTIK & THERAPIE
    28. Roder, JD; Thorban, S; Pantel, K; Siewert, JR
      Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer

      WORLD JOURNAL OF SURGERY
    29. Pantel, K
      Introductory overview

      CANCER AND METASTASIS REVIEWS
    30. Braun, S; Pantel, K
      Biological characteristics of micrometastatic cancer cells in bone marrow

      CANCER AND METASTASIS REVIEWS
    31. Riethmuller, G; Klein, CA; Pantel, K
      Hunting down the seminal cells of clinical metastases

      IMMUNOLOGY TODAY
    32. Scheunemann, P; Izbicki, JR; Pantel, K
      Tumorigenic potential of apparently tumor-free lymph nodes

      NEW ENGLAND JOURNAL OF MEDICINE
    33. Klein, CA; Schmidt-Kittler, O; Schardt, JA; Pantel, K; Speicher, MR; Riethmuller, G
      Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    34. Offner, S; Schmaus, W; Witter, K; Baretton, GB; Schlimok, G; Passlick, B; Riethmuller, G; Pantel, K
      p53 gene mutations are not required for early dissemination of cancer cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    35. Ahr, A; Scharl, A; Muller, M; von Minckwitz, G; Gatje, R; Pantel, K; Kaufmann, M
      Cross-reactive staining of normal bone-marrow cells by monoclonal antibody2E11

      INTERNATIONAL JOURNAL OF CANCER
    36. Kollermann, J; Heseding, B; Helpap, B; Kollermann, MW; Pantel, K
      Comparative immunocytochemical assessment of isolated carcinoma cells in lymph nodes and bone marrow of patients with clinically localized prostate cancer

      INTERNATIONAL JOURNAL OF CANCER
    37. Braun, S; Hepp, F; Sommer, HL; Pantel, K
      Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease

      INTERNATIONAL JOURNAL OF CANCER
    38. Putz, E; Witter, K; Offner, S; Stosiek, P; Zippelius, A; Johnson, J; Zahn, R; Riethmuller, C; Pantel, K
      Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases

      CANCER RESEARCH
    39. Passlick, B; Kubuschok, B; Izbicki, JR; Thetter, O; Pantel, K
      Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer

      ANNALS OF THORACIC SURGERY
    40. Pantel, K; Cote, RJ; Fodstad, O
      Detection and clinical importance of micrometastatic disease

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    41. PASSLICK B; SEENHILBER R; WOCKEL W; HAUSSINGER K; THETTER O; PANTEL K
      THE 17-1A ANTIGEN IS EXPRESSED ON PRIMARY, METASTATIC AND DISSEMINATED NONSMALL CELL LUNG-CARCINOMA CELLS

      Annals of oncology
    42. BRAUN S; HEPP F; JANNI W; SOMMER HL; PANTEL K
      REDUCTION OF MICROMETASTATIC TUMOR LOAD BY MONOCLONAL-ANTIBODY THERAPY - INFLUENCE OF TUMOR-ANTIGEN HETEROGENEITY

      Annals of oncology
    43. PANTEL K; PASSLICK B; VOGT J; STOSIEK P; ANGSTWURM M; SEENHIBLER R; HAUSSINGER K; THETTER O; IZBICKI JR; RIETHMULLER G
      REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER

      Journal of clinical oncology
    44. ZIPPELIUS A; RIETHMULLER G; PANTEL K
      REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS - REPLY

      Journal of clinical oncology
    45. Braun, S; Pantel, K
      Prognostic significance of micrometastatic bone marrow involvement

      BREAST CANCER RESEARCH AND TREATMENT
    46. PANTEL K; AHR A
      IMMUNOCYTOCHEMICAL AND MOLECULAR STRATEGIES FOR THE DETECTION OF MICROMETASTASES IN PATIENTS WITH SOLID EPITHELIAL TUMORS - A REVIEW

      Nuclear medicine communications
    47. HOSCH SB; PANTEL K; IZBICKI JR
      CRYPTIC TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH ESOPHAGEAL CANCER- REPLY

      The New England journal of medicine
    48. BORELLI S; SCHADENDORF D; RIETHMULLER G; PANTEL K
      IMMUNOHISTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF MELANOMA PATIENTS

      Journal of investigative dermatology
    49. HOSCH SB; INNDORF S; BULL S; STERN F; PANTEL K; IZBICKI JR
      IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS 3D55 AND CD59 IN ESOPHAGEAL CANCER

      Gastroenterology
    50. HOSCH SB; STOECKLEIN NH; IZBICKI JR; PICHLMEIER U; PANTEL K
      REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN PATIENTS WITH ESOPHAGEAL CANCER

      Gastroenterology
    51. INNDORF S; HOSCH SB; LUETH M; SCHEUNEMANN P; PANTEL K; KNOEFEL WT; IZBICKI JR
      IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS CD55 AND CD59 IN LIVER METASTASES OF COLON-CANCER

      Gastroenterology
    52. SCHEUNEMANN P; HOSCH SB; WITTER K; PUTZ E; ZAHN R; SCHNEIDER C; PANTEL K; REEDERS A; IZBICKI JR
      ESTABLISHMENT AND COMPARATIVE CHARACTERIZATION OF 2 NEW HUMAN ESOPHAGEAL-CARCINOMA CELL-LINES DERIVED FROM LYMPH-NODE MICROMETASTATIC CELLSAND AUTOLOGOUS PRIMARY TUMOR

      Gastroenterology
    53. GATH HJ; HEISSLER E; HELL B; JEHLE M; PANTEL K; BIER J
      MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS IN THE HEAD AND NECK REGION

      British Journal of Cancer
    54. IZBICKI JR; PASSLICK B; PANTEL K; PICHLMEIER U; HOSCH SB; KARG O; THETTER O
      EFFECTIVENESS OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY IN PATIENTS WITH RESECTABLE NONSMALL CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL

      Annals of surgery
    55. BRAUN S; MULLER M; HEPP F; SCHLIMOK G; RIETHMULLER G; PANTEL K
      MICROMETASTATIC BREAST-CANCER CELLS IN BONE-MARROW AT PRIMARY SURGERY- PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS

      Journal of the National Cancer Institute
    56. PASSLICK B; PANTEL K; IZBICKI JR; THETTER O
      DETECTION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITHRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - LONG-TERM RESULTS AFTER 5 YEARS OF FOLLOW-UP

      European journal of cancer
    57. ZIPPELIUS A; KUFER P; HONOLD G; KOLLERMANN MW; OBERNEDER R; SCHLIMOK G; RIETHMULLER G; PANTEL K
      LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW

      Journal of clinical oncology
    58. IZBICKI JR; HOSCH SB; PICHLMEIER U; REHDERS A; BUSCH C; NIENDORF A; PASSLICK B; BROELSCH CE; PANTEL K
      PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICALLY IDENTIFIABLE TUMOR-CELLS INLYMPH-NODES OF PATIENTS WITH COMPLETELY RESECTED ESOPHAGEAL CANCER

      The New England journal of medicine
    59. HOSCH SB; IZBICKI JR; PICHLMEIER U; STOECKLEIN N; NIENDORF A; KNOEFEL WT; BROELSCH CE; PANTEL K
      EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOREGULATORY MOLECULES IN ESOPHAGEAL CANCER

      International journal of cancer
    60. PANTEL K; ENZMANN T; KOLLERMANN J; CAPRANO J; RIETHMULLER C; KOLLERMANN MW
      IMMUNOCYTOCHEMICAL MONITORING OF MICROMETASTATIC DISEASE - REDUCTION OF PROSTATE-CANCER CELLS IN BONE-MARROW BY ANDROGEN DEPRIVATION

      International journal of cancer
    61. HOCHTLENVOLLMAR W; GRUBER R; BODENMULLER H; LINDEMANN F; PASSLICK B; SCHLIMOK G; PANTEL K; RIETHMULLER G
      OCCULT EPITHELIAL TUMOR-CELLS DETECTED IN BONE-MARROW BY AN ENZYME-IMMUNOASSAY SPECIFIC FOR CYTOKERATIN-19

      International journal of cancer
    62. PANTEL K; DOEBERITZ MV; IZBICKI JR; RIETHMULLER G
      DISSEMINATED TUMOR-CELLS - DIAGNOSIS, PROGNOSTIC VALUE, PHENOTYPING AND THERAPEUTIC STRATEGY

      Chirurg
    63. BRAUN S; HEPP F; SOMMER HL; RIETHMULLER G; PANTEL K
      HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY

      Blood
    64. BRAUN S; MULLER M; HEPP F; JANNI W; KINDERMANN G; RIETHMULLER G; PANTEL K
      OCCULT HEMATOGENOUS DISSEMINATION OF CARCINOMA-CELLS IN PATIENTS WITHOVARIAN-CANCER

      Blood
    65. PANTEL K; PUTZ E; RIETHMULLER G
      IDENTIFICATION OF NEW THERAPEUTIC TARGETS ON BONE-MARROW MICROMETASTASES

      Blood
    66. SCHALLER G; FUCHS I; PRITZE W; EBERT A; HERBST H; PANTEL K; WEITZEL H; LENGYEL E
      ELEVATED KERATIN-18 PROTEIN EXPRESSION INDICATES A FAVORABLE PROGNOSIS IN PATIENTS WITH BREAST-CANCER

      Clinical cancer research
    67. THORBAN S; RODER JD; PANTEL K; SIEWERT JR
      EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA DETECTED BY IMMUNOCYTOCHEMICAL STAINING

      European journal of cancer
    68. PASSLICK B; PANTEL K; KUBUSCHOK B; ANGSTWURM M; NEHER A; THETTER O; SCHWEIBERER L; IZBICKI JR
      EXPRESSION OF MHC MOLECULES AND ICAM-1 ON NON-SMALL-CELL LUNG CARCINOMAS - ASSOCIATION WITH EARLY LYMPHATIC SPREAD OF TUMOR-CELLS

      European journal of cancer
    69. PANTEL K; RIETHMULLER G
      METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES

      Onkologie
    70. THORBAN S; RODER JD; NEKARDA H; FUNK A; PANTEL K; SIEWERT JR
      DISSEMINATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH ESOPHAGEAL CANCER - DETECTION AND PROGNOSTIC-SIGNIFICANCE

      World journal of surgery
    71. PANTEL K; IZBICKI J; PASSLICK B; ANGSTWURM M; HAUSSINGER K; THETTER O; RIETHMULLER G
      FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER WITHOUT OVERT METASTASES

      Lancet
    72. THORBAN S; RODER JD; PANTEL K; SIEWERT JR
      IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINA TED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA

      Zentralblatt fur Chirurgie
    73. PASSLICK B; PANTEL K
      PROGNOSTIC FACTORS IN STAGE-I NONSMALL CE LL LUNG-CANCER

      Zentralblatt fur Chirurgie
    74. PASSLICK B; THETTER O; PANTEL K; IZBICKI JR
      LIMITS OF SURGERY IN PATIENTS WITH APPARE NTLY LOCALIZED NONSMALL CELL LUNG-CANCER (PT1-3, PNO, MO)

      Langenbecks Archiv fur Chirurgie
    75. PASSLICK B; PANTEL K; STOSIEK P; HOSCH S; THETTER O; IZBICKI JR
      EXPRESSION OF PLAKOGLOBIN IN LUNG-CANCER - FREQUENCY AND PROGNOSTIC-SIGNIFICANCE

      Langenbecks Archiv fur Chirurgie
    76. IZBICKI JR; PASSLICK B; HOSCH SB; KUBUSCHOCK B; SCHNEIDER C; BUSCH C; KNOEFEL WT; THETTER O; PANTEL K
      MODE OF SPREAD IN THE EARLY PHASE OF LYMPHATIC METASTASIS IN NON-SMALL-CELL LUNG-CANCER - SIGNIFICANCE OF NODAL MICROMETASTASIS

      Journal of thoracic and cardiovascular surgery
    77. HOSCH SB; REHDERS A; PASSLICK B; SCHNEIDER C; PANTEL K; IZBICKI JR
      MINIMAL TUMOR-CELL DISSEMINATION IN ESOPHAGEAL CANCER - A CONTRADICTION TO LOCAL TREATMENT

      Gastroenterology
    78. ORUZIO D; PANTEL K; HEMPEL D; LINDEMANN F; WITTE J; PERSSON B; RIETHMULLER G; SCHLIMOK G
      EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER

      Blood
    79. PANTEL K; BRAUN S; SCHLIMOK G; RIETHMULLER G
      BIOLOGICAL HETEROGENEITY OF MICROMETASTATIC BREAST-CANCER CELLS - CLINICAL IMPLICATIONS

      Blood
    80. ZIPPELIUS A; KUFER P; HONOLD G; RIETHMULLER G; PANTEL K
      LIMITATIONS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW

      Blood
    81. PASSLICK B; IZBICKI JR; KUBUSCHOK B; THETTER O; PANTEL K
      DETECTION OF DISSEMINATED LUNG-CANCER CELLS IN LYMPH-NODES - IMPACT ON STAGING AND PROGNOSIS

      The Annals of thoracic surgery
    82. THORBAN S; RODER JD; PANTEL K; SIEWERT R
      IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA

      The American journal of surgery
    83. TERPE HJ; STORKEL S; ZIMMER U; ANQUEZ V; FISCHER C; PANTEL K; GUNTHERT U
      EXPRESSION OF CD44 ISOFORMS IN RENAL-CELL TUMORS - POSITIVE CORRELATION TO TUMOR DIFFERENTIATION

      The American journal of pathology
    84. THORBAN S; RODER JD; NEKARDA H; FUNK A; SIEWERT JR; PANTEL K
      IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINATED TUMOR-CELLS IN THE BONE-MARROW OF PATIENTS WITH ESOPHAGEAL-CARCINOMA

      Journal of the National Cancer Institute
    85. SCHLIMOK G; PANTEL K; LOIBNER H; FACKLERSCHWALBE I; RIETHMULLER G
      REDUCTION OF METASTATIC CARCINOMA-CELLS IN BONE-MARROW BY INTRAVENOUSLY ADMINISTERED MONOCLONAL-ANTIBODY - TOWARDS A NOVEL SURROGATE TEST TO MONITOR ADJUVANT THERAPIES OF SOLID TUMORS

      European journal of cancer
    86. PANTEL K; AIGNHERR C; KOLLERMANN J; CAPRANO J; RIETHMULLER G; KOLLERMANN MW
      IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH UNTREATED STAGE-C PROSTATIC-CANCER

      European journal of cancer
    87. PANTEL K; RIETHMULLER G
      IMMUNOTHERAPEUTIC APPROACHES DIRECTED AGAINST MINIMAL RESIDUAL CANCER

      European journal of cancer
    88. GATH HJ; HEISSLER E; HELL B; BIER J; RIETHMULLER G; PANTEL K
      IMMUNOCYTOLOGIC DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION

      International journal of oral and maxillofacial surgery
    89. BRAUN S; PANTEL K
      IMMUNOLOGICAL APPROACHES TO DETECT AND CHARACTERIZE INDIVIDUAL MICRODISSEMINATED COLON-CANCER CELLS

      Journal of experimental & clinical cancer research
    90. PANTEL K; RIETHMULLER G
      METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES

      Onkologie
    91. ZIPPELIUS A; HONOLD G; KUFER P; SCHLIMOK G; RIETHMULLER G; PANTEL K
      POTENTIAL AND LIMITATIONS OF RT-PCR FOR DETECTION OF ISOLATED CARCINOMA-CELLS IN BONE-MARROW

      Experimental hematology
    92. BRAUN S; HEPP F; MAASSEN V; KINDERMANN G; RIETHMULLER G; PANTEL K
      DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITHBREAST, CERVICAL, AND OVARIAN-CANCER

      Experimental hematology
    93. BRAUN S; ANGSTWURM M; KUTTER D; VOGT J; SCHMAUS W; SCHLIMOK G; RIETHMULLER G; PANTEL K
      PHENOTYPE OF DISSEMINATED CARCINOMA-CELLS IN BONE-MARROW

      Experimental hematology
    94. BRAUN S; PANTEL K
      IMMUNODIAGNOSIS AND IMMUNOTHERAPY OF ISOLATED TUMOR-CELLS DISSEMINATED TO BONE-MARROW OF PATIENTS WITH COLORECTAL-CANCER

      Tumori
    95. PANTEL K; GATH H
      STAGING OF HEAD AND NECK-CANCER

      The New England journal of medicine
    96. PASSLICK B; IZBICKI JR; HAUSSINGER K; THETTER O; PANTEL K
      IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IS NOT ASSOCIATED WITH APOOR-PROGNOSIS IN NON-SMALL-CELL LUNG-CANCER

      Journal of thoracic and cardiovascular surgery
    97. FLIEGER D; GRUBER R; SCHLIMOK G; REITER C; PANTEL K; RIETHMULLER G
      A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS

      Journal of immunological methods
    98. PASSLICK B; IZBICKI JR; REHDERS A; KNOEFEL WT; HOSCH SB; PANTEL K; BROELSCH CE
      LYMPH-NODE MICROMETASTASES IN PATIENTS WITH ESOPHAGEAL-CARCINOMA

      Gastroenterology
    99. PASSLICK B; THETTER O; PANTEL K; KUBUSCHOK B; PICHLMEIER U; IZBICKI JR
      RELEVANCE OF REGIONAL LYMPHATIC TUMOR-CEL L DISSEMINATION IN PATIENTSWITH RESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE-STUDY

      Chirurg
    100. IZBICKI JR; PASSLICK B; KARG O; BLOECHLE C; PANTEL K; KNOEFEL WT; THETTER O
      IMPACT OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY ON TUMOR STAGING IN LUNG-CANCER

      The Annals of thoracic surgery


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/01/21 alle ore 13:20:27